Source: What Now News 24

On Sunday afternoon, a massive explosion at a pharmaceutical company in Taoyuan city in Taiwan injured two workers. Soon after the explosion, a fire broke out in the Sci Pharmtech Inc., which spread quickly to five nearby factories. It was reported that the explosion was heard from the Tamsui District in New Taipei City. After the explosion, thick black smoke was seen coming out from Sci Pharmtech Inc.

The firefighting department responded quickly to the fire, and contained the fire quickly. Firetrucks were deployed from the closely airport of Taoyuan airport. No flights have been affected by the thick black smoke.

Around 76 personnel, 28 fire equipment pieces and 2 ambulances were deployed to the area. The workers injured includes a Philippine worker. Both were taken to Chang Gung Memorial Hospital. The 30-year old Philippine worker is in critical condition after suffering third-degree burns to 90% of his body. He is currently intubated and treated at the specialist burn unit. The other worker, a Taiwanese, suffered a burn to one hand. He was held at the hospital for observation, but was than released after eight hours.

An investigation has been launched to determine the cause of the massive explosion. It has been reported by Liberty Times, that the pharmaceutical company produces hydroxychloroquine APIs. The company is considered to be the second largest hydroxychloroquine raw material supplier in the world.

On the same day, a Chinese aircraft carrier and four other navy warships passed through Taiwan strait in the direction of the South China Sea.

Update: Filipino worker succumbed to his injuries on Monday.









Related: Hydroxychloroquine factory on fire after explosion: Taiwan

The AMA Quietly Admits They Lied About Hydroxychloroquine

A massive hydroxychloroquine meta-analysis (156 studies) has just been updated (version 28!).It says that HCQ works beyond all statistical doubt.

Peer-reviewed hydroxychloroquine study finds 84% fewer hospitalizations among early treated outpatients

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

HCQ Protocols from America’s Frontline Doctors

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »